我们必须超越初级强化,了解女性的尼古丁使用情况
Kathleen R McNealy1, Scott T Barrett2, Rick A Bevins2
1University of Kentucky, College of Medicine, Department of Pharmacology and Nutritional Sciences, United States.
Frontiers in neuroendocrinology
|January 13, 2026
概括
女性更容易受到尼古丁成的影响,并且由于荷尔蒙的影响,更难戒烟. 了解激素如何影响环境线索是开发更好的女性戒烟治疗的关键.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 与男性相比,女性对尼古丁依赖的脆弱性更高,戒烟治疗的成功率更低.
- 荷尔蒙因素,包括雌激素和孕激素,显著影响女性的尼古丁使用和戒烟结果.
- 现有的戒烟策略往往无法解释特定于性别的生物和行为机制.
研究的目的:
- 审查当前对性类固醇激素如何调节女性尼古丁使用的理解.
- 探索环境刺激对女性吸烟行为的作用及其与荷尔蒙影响的相互作用.
- 提出新的研究方向,重点关注动物模型中的非初级强化机制,以改善戒烟疗法.
主要方法:
- 文献综述综合了关于尼古丁使用和戒断中的性别差异的研究.
- 对自然和合成性激素对人类和动物模型中尼古丁摄入量影响的研究分析.
- 检查环境线索对尼古丁自我管理和吸烟行为的影响.
主要成果:
- 高水平的雌激素与增加的吸烟和戒烟困难相关,而高水平的孕激素与减少吸烟和更好的戒烟成功有关.
- 荷尔蒙避孕药可以显著改变尼古丁使用的结果,反映或超过自然的荷尔蒙波动.
- 与尼古丁的主要强化作用相比,女性的吸烟行为受到环境刺激 (例如,感官线索) 的不成比例的影响.
结论:
- 性类固醇激素在通过复杂的行为途径调节尼古丁使用和戒烟结果方面发挥着至关重要的作用.
- 环境因素是女性尼古丁摄入的关键媒介,这表明需要在戒烟干预中针对这些因素.
- 未来的研究应该研究性类固醇激素对非初级强化因子的调节,特别是环境暗示反应,在人类和动物模型中,以提高女性戒烟的有效性.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
2.0K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K
Stimulants
828
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
828
CNS Depressants: Alcohol and Nicotine
1.0K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.0K
Drug Dependence
1.6K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.6K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Cholinergic Receptors: Nicotinic
5.3K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
5.3K


